167 related articles for article (PubMed ID: 25899043)
1. Circulating adiponectin, leptin and adiponectin-leptin ratio and endometrial cancer risk: Evidence from a meta-analysis of epidemiologic studies.
Gong TT; Wu QJ; Wang YL; Ma XX
Int J Cancer; 2015 Oct; 137(8):1967-78. PubMed ID: 25899043
[TBL] [Abstract][Full Text] [Related]
2. Adipocytokines and their relationship to endometrial cancer risk: A systematic review and meta-analysis.
Ellis PE; Barron GA; Bermano G
Gynecol Oncol; 2020 Aug; 158(2):507-516. PubMed ID: 32507648
[TBL] [Abstract][Full Text] [Related]
3. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
[TBL] [Abstract][Full Text] [Related]
4. Circulating adiponectin and risk of endometrial cancer.
Zheng Q; Wu H; Cao J
PLoS One; 2015; 10(6):e0129824. PubMed ID: 26030130
[TBL] [Abstract][Full Text] [Related]
5. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
[TBL] [Abstract][Full Text] [Related]
6. Case-control study of markers of insulin resistance and endometrial cancer risk.
Friedenreich CM; Langley AR; Speidel TP; Lau DC; Courneya KS; Csizmadi I; Magliocco AM; Yasui Y; Cook LS
Endocr Relat Cancer; 2012 Dec; 19(6):785-92. PubMed ID: 23033315
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin and Endometrial Cancer: A Systematic Review and Meta-Analysis.
Zeng F; Shi J; Long Y; Tian H; Li X; Zhao AZ; Li RF; Chen T
Cell Physiol Biochem; 2015; 36(4):1670-8. PubMed ID: 26160484
[TBL] [Abstract][Full Text] [Related]
8. Association between adiponectin levels and endometrial carcinoma risk: evidence from a dose-response meta-analysis.
Lin T; Zhao X; Kong WM
BMJ Open; 2015 Sep; 5(9):e008541. PubMed ID: 26338840
[TBL] [Abstract][Full Text] [Related]
9. Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study.
Dimou NL; Papadimitriou N; Mariosa D; Johansson M; Brennan P; Peters U; Chanock SJ; Purdue M; Bishop DT; Gago-Dominquez M; Giles GG; Moreno V; Platz EA; Tangen CM; Wolk A; Zheng W; Wu X; Campbell PT; Giovannucci E; Lin Y; ; Gunter MJ; Murphy N
Int J Cancer; 2021 Apr; 148(7):1625-1636. PubMed ID: 33038280
[TBL] [Abstract][Full Text] [Related]
10. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
11. Associations of coffee consumption with circulating level of adiponectin and leptin. A meta-analysis of observational studies.
Zhang Y; Zhang DZ
Int J Food Sci Nutr; 2018 Dec; 69(8):1003-1012. PubMed ID: 29513118
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin to leptin index as a marker of endometrial cancer in postmenopausal women with abnormal vaginal bleeding: an observational study.
Nowosielski K; Pozowski J; Ulman-Włodarz I; Romanik M; Poręba R; Sioma-Markowska U
Neuro Endocrinol Lett; 2012; 33(2):217-23. PubMed ID: 22592205
[TBL] [Abstract][Full Text] [Related]
13. High leptin level is an independent risk factor of endometrial cancer: a meta-analysis.
Wang PP; He XY; Wang R; Wang Z; Wang YG
Cell Physiol Biochem; 2014; 34(5):1477-84. PubMed ID: 25322729
[TBL] [Abstract][Full Text] [Related]
14. Evaluating vaspin and adiponectin in postmenopausal women with endometrial cancer.
Erdogan S; Sezer S; Baser E; Gun-Eryilmaz O; Gungor T; Uysal S; Yilmaz FM
Endocr Relat Cancer; 2013 Oct; 20(5):669-75. PubMed ID: 23896633
[TBL] [Abstract][Full Text] [Related]
15. Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece.
Petridou E; Mantzoros C; Dessypris N; Koukoulomatis P; Addy C; Voulgaris Z; Chrousos G; Trichopoulos D
J Clin Endocrinol Metab; 2003 Mar; 88(3):993-7. PubMed ID: 12629074
[TBL] [Abstract][Full Text] [Related]
16. Association of circulating leptin and adiponectin levels with colorectal cancer risk: A systematic review and meta-analysis of case-control studies.
Wang Y; Li J; Fu X; Li J; Liu L; Alkohlani A; Tan SC; Low TY; Hou Y
Cancer Epidemiol; 2021 Aug; 73():101958. PubMed ID: 34020315
[TBL] [Abstract][Full Text] [Related]
17. Abdominal adiposity through adipocyte secretion products, a risk factor for endometrial cancer.
Mihu D; Ciortea R; Mihu CM
Gynecol Endocrinol; 2013 May; 29(5):448-51. PubMed ID: 23544715
[TBL] [Abstract][Full Text] [Related]
18. Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis.
Burton AJ; Gilbert R; Tilling K; Langdon R; Donovan JL; Holly JMP; Martin RM
Sci Rep; 2021 Jan; 11(1):320. PubMed ID: 33431998
[TBL] [Abstract][Full Text] [Related]
19. Dietary fatty acids intake and endometrial cancer risk: a dose-response meta-analysis of epidemiological studies.
Wu QJ; Gong TT; Wang YZ
Oncotarget; 2015 Nov; 6(34):36081-97. PubMed ID: 26462150
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol consumption and risk of endometrial cancer: a systematic review and dose-response meta-analysis of observational studies.
Gong TT; Li D; Wu QJ; Wang YZ
Oncotarget; 2016 Mar; 7(13):16996-7008. PubMed ID: 26959738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
